Literature DB >> 21297326

A case of membranous nephropathy with primary biliary cirrhosis and cyclosporine-induced remission.

Yusuke Sakamaki1, Matsuhiko Hayashi, Shu Wakino, Seiichi Fukuda, Kounosuke Konishi, Akinori Hashiguchi, Koichi Hayashi, Hiroshi Itoh.   

Abstract

We report a case of membranous nephropathy with primary biliary cirrhosis (PBC). A 76-year-old Japanese man had been treated for PBC and was referred to our department because of acute severe proteinuria (10 g/day). Renal biopsy was performed and was compatible with a diagnosis of membranous nephropathy. The patient was treated with cyclosporine A (CsA; Neoral®), which was followed by normalization of liver function and partial remission of proteinuria (0.68 g/day) within six months without any significant side effects. This case suggests that CsA monotherapy is effective for the treatment of both liver dysfunction and membranous nephropathy associated with PBC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297326     DOI: 10.2169/internalmedicine.50.4020

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis.

Authors:  Shuzo Sato; Rie Saito; Haruyo Iwadate; Tomoyuki Asano; Kazumichi Abe; Atsushi Takahashi; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2012-07-20

2.  Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study.

Authors:  Li Wang; Feng-Chun Zhang; Hua Chen; Xuan Zhang; Dong Xu; Yong-Zhe Li; Qian Wang; Li-Xia Gao; Yun-Jiao Yang; Fang Kong; Ke Wang
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

3.  Progressive chronic kidney disease secondary to tubulointerstitial nephritis in primary biliary cirrhosis.

Authors:  Tarun Bansal; Anna Takou; Arif Khwaja
Journal:  Clin Kidney J       Date:  2012-08-20

4.  QTc interval prolongation in the patients with primary biliary cholangitis.

Authors:  Zihao Wang; Rongkai Qian; Yanhua Wang; Lingfei Mo; Bomiao Ju; Nan Hu; Pei Wang; Lan He; Jing Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-02       Impact factor: 1.468

5.  Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases.

Authors:  Maxime Dauvergne; Anissa Moktefi; Marion Rabant; Cécile Vigneau; Tomek Kofman; Stephane Burtey; Christophe Corpechot; Thomas Stehlé; Dominique Desvaux; Nathalie Rioux-Leclercq; Philippe Rouvier; Bertrand Knebelmann; Jean-Jacques Boffa; Thierry Frouget; Eric Daugas; Mathieu Jablonski; Karine Dahan; Isabelle Brocheriou; Philippe Remy; Philippe Grimbert; Philippe Lang; Oliver Chazouilleres; Dil Sahali; Vincent Audard
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 6.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28

7.  Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.

Authors:  Sainan Bian; Hua Chen; Li Wang; Yunyun Fei; Yunjiao Yang; Linyi Peng; Yongzhe Li; Fengchun Zhang
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.